Q32 Bio, Inc. (QTTB)
8.23
-0.02
(-0.24%)
USD |
NASDAQ |
Oct 02, 16:00
8.24
+0.01
(+0.12%)
After-Hours: 20:00
Q32 Bio Market Cap : 195.35M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 195.35M |
| October 01, 2026 | 195.83M |
| September 30, 2026 | 196.30M |
| September 29, 2026 | 226.21M |
| September 28, 2026 | 219.09M |
| September 25, 2026 | 208.17M |
| September 24, 2026 | 218.85M |
| September 23, 2026 | 226.92M |
| September 22, 2026 | 250.90M |
| September 21, 2026 | 248.52M |
| September 18, 2026 | 250.18M |
| September 17, 2026 | 257.78M |
| September 16, 2026 | 260.63M |
| September 15, 2026 | 265.14M |
| September 14, 2026 | 258.97M |
| September 11, 2026 | 263.48M |
| September 10, 2026 | 254.46M |
| September 09, 2026 | 264.43M |
| September 08, 2026 | 277.48M |
| September 04, 2026 | 284.60M |
| September 03, 2026 | 303.83M |
| September 02, 2026 | 322.58M |
| September 01, 2026 | 340.86M |
| August 31, 2026 | 352.96M |
| August 28, 2026 | 356.76M |
| Date | Value |
|---|---|
| August 27, 2026 | 383.35M |
| August 26, 2026 | 384.06M |
| August 25, 2026 | 387.38M |
| August 24, 2026 | 388.33M |
| August 21, 2026 | 379.07M |
| August 20, 2026 | 376.46M |
| August 19, 2026 | 375.99M |
| August 18, 2026 | 362.93M |
| August 17, 2026 | 378.60M |
| August 14, 2026 | 359.61M |
| August 13, 2026 | 364.83M |
| August 12, 2026 | 364.83M |
| August 11, 2026 | 365.78M |
| August 10, 2026 | 371.95M |
| August 07, 2026 | 370.29M |
| August 06, 2026 | 384.53M |
| August 05, 2026 | 391.42M |
| August 04, 2026 | 383.46M |
| August 03, 2026 | 359.97M |
| July 31, 2026 | 229.39M |
| July 30, 2026 | 227.64M |
| July 29, 2026 | 214.18M |
| July 28, 2026 | 229.83M |
| July 27, 2026 | 222.51M |
| July 24, 2026 | 221.64M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Intellia Therapeutics, Inc. | 1.717B |
| Beam Therapeutics, Inc. | 2.530B |
| Prime Medicine, Inc. | 538.60M |
| Prelude Therapeutics, Inc. | 292.71M |
| Twist Bioscience Corp. | 11.82B |
Market Cap Related Metrics
| PE Ratio | 2.742 |
| PS Ratio | 2.269 |
| Price to Book Value | 1.845 |
| Price | 8.23 |
| Earnings Yield | 36.47% |
| Operating PE Ratio | 5.682 |
| Normalized PE Ratio | 2.738 |